Comprehensive Laboratory Testing For Adoptive Cell Therapies: Supporting Preclinical And Clinical Testing To Advance Your Precision Medicine Initiative

Adoptive cell therapies (ACTs) offer revolutionary approaches to patient care, from tumor-infiltrating lymphocytes to gene-modified T-cells with novel T-cell receptors, chimeric antigen receptor T-cells (CAR T), and CAR natural killer cells. We provide comprehensive laboratory assessments throughout the entire development process, offering support for the unique challenges and complexities that arise when developing these precision medicines.

Our services include preclinical, CMC release, and clinical testing across both our in-house and specialty laboratories. By collaborating closely with you, we will tailor a custom strategy that provides the expert support needed to advance your impactful ACT projects.